MedPath

The effect of an isocaloric, protein- and mineral-enriched ('postdischarge') formula on growth, body composition and bone mineralization of late preterm infants.;Follow-up: The effect of an isocaloric, protein- and mineral-enriched (*postdischarge*) formula on growth, body composition and neurocognitive development of late preterm infants at the corrected age of 2 years.

Completed
Conditions
(inhaal) groei, hypertensie, cognitieve/motorische/taal-ontwikkeling
(catch up) growth
metabolic syndrome
10013296
Registration Number
NL-OMON55631
Lead Sponsor
Vrije Universiteit Medisch Centrum
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
300
Inclusion Criteria

Birth at gestational age between 32 0/7 and 35 6/7 weeks., Follow-up:
participants of the LEGO-study

Exclusion Criteria

- gastro-intestinal surgery and disease known to influence growth (i.e. cystic
fibrosis and severe gastro-oesophageal reflux)
- known presence of growth hormone, IGF-1 or other pituitary hormone
deficiencies
- concurrent therapies with substances known or suspected to be associated with
alteration of growth (i.e. oral steroids)
- cardiac, renal, pulmonary and liver disease
- chromosomal and/or genetic syndromes
- known skeletal disease
- severe illness in general

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>Primary objective: to compare growth and body composition between late preterm<br /><br>infants at 6 months corrected age, fed either isocaloric, protein- en<br /><br>mineral-enriched postdischarge formula or standard term formula between term<br /><br>age and 6 months corrected age.<br /><br><br /><br>- growth; weight, length and headcircumference<br /><br>- body composition; fat mass and fat free mass<br /><br><br /><br>Follow-up:<br /><br>- growth: Weight, length, head circumference, waist circumference,<br /><br>- body composition: fat mass and fat free mass</p><br>
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath